These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 21413014)
1. Hemin, an iron-binding porphyrin, inhibits HIF-1α induction through its binding with heat shock protein 90. Lee JM; Lee WH; Kay HY; Kim ES; Moon A; Kim SG Int J Cancer; 2012 Feb; 130(3):716-27. PubMed ID: 21413014 [TBL] [Abstract][Full Text] [Related]
2. Oltipraz and dithiolethione congeners inhibit hypoxia-inducible factor-1alpha activity through p70 ribosomal S6 kinase-1 inhibition and H2O2-scavenging effect. Lee WH; Kim YW; Choi JH; Brooks SC; Lee MO; Kim SG Mol Cancer Ther; 2009 Oct; 8(10):2791-802. PubMed ID: 19789218 [TBL] [Abstract][Full Text] [Related]
3. A group of novel HIF-1α inhibitors, glyceollins, blocks HIF-1α synthesis and decreases its stability via inhibition of the PI3K/AKT/mTOR pathway and Hsp90 binding. Lee SH; Jee JG; Bae JS; Liu KH; Lee YM J Cell Physiol; 2015 Apr; 230(4):853-62. PubMed ID: 25204544 [TBL] [Abstract][Full Text] [Related]
4. C-Terminal HSP90 Inhibitors Block the HIF-1 Hypoxic Response by Degrading HIF-1α through the Oxygen-Dependent Degradation Pathway. Kataria N; Martinez CA; Kerr B; Zaiter SS; Morgan M; McAlpine SR; Cook KM Cell Physiol Biochem; 2019; 53(3):480-495. PubMed ID: 31486323 [TBL] [Abstract][Full Text] [Related]
5. Wogonin inhibits tumor angiogenesis via degradation of HIF-1α protein. Song X; Yao J; Wang F; Zhou M; Zhou Y; Wang H; Wei L; Zhao L; Li Z; Lu N; Guo Q Toxicol Appl Pharmacol; 2013 Sep; 271(2):144-55. PubMed ID: 23707765 [TBL] [Abstract][Full Text] [Related]
6. Effects of geldanamycin on HIF-1alpha mediated angiogenesis and invasion in prostate cancer cells. Alqawi O; Moghaddas M; Singh G Prostate Cancer Prostatic Dis; 2006; 9(2):126-35. PubMed ID: 16432534 [TBL] [Abstract][Full Text] [Related]
7. Degradation of HIF-1alpha under hypoxia combined with induction of Hsp90 polyubiquitination in cancer cells by hypericin: a unique cancer therapy. Barliya T; Mandel M; Livnat T; Weinberger D; Lavie G PLoS One; 2011; 6(9):e22849. PubMed ID: 21949677 [TBL] [Abstract][Full Text] [Related]
8. Effects of 12 metal ions on iron regulatory protein 1 (IRP-1) and hypoxia-inducible factor-1 alpha (HIF-1alpha) and HIF-regulated genes. Li Q; Chen H; Huang X; Costa M Toxicol Appl Pharmacol; 2006 Jun; 213(3):245-55. PubMed ID: 16386771 [TBL] [Abstract][Full Text] [Related]
9. Thymoquinone affects hypoxia-inducible factor-1α expression in pancreatic cancer cells via HSP90 and PI3K/AKT/mTOR pathways. Zhao ZX; Li S; Liu LX World J Gastroenterol; 2024 Jun; 30(21):2793-2816. PubMed ID: 38899332 [TBL] [Abstract][Full Text] [Related]
10. AT-533, a novel Hsp90 inhibitor, inhibits breast cancer growth and HIF-1α/VEGF/VEGFR-2-mediated angiogenesis in vitro and in vivo. Zhang PC; Liu X; Li MM; Ma YY; Sun HT; Tian XY; Wang Y; Liu M; Fu LS; Wang YF; Chen HY; Liu Z Biochem Pharmacol; 2020 Feb; 172():113771. PubMed ID: 31863779 [TBL] [Abstract][Full Text] [Related]
11. Hypoxia-inducible factor-1α inhibition by a pyrrolopyrazine metabolite of oltipraz as a consequence of microRNAs 199a-5p and 20a induction. Kang SG; Lee WH; Lee YH; Lee YS; Kim SG Carcinogenesis; 2012 Mar; 33(3):661-9. PubMed ID: 22223846 [TBL] [Abstract][Full Text] [Related]
12. Induction of the hypoxia-inducible factor system by low levels of heat shock protein 90 inhibitors. Ibrahim NO; Hahn T; Franke C; Stiehl DP; Wirthner R; Wenger RH; Katschinski DM Cancer Res; 2005 Dec; 65(23):11094-100. PubMed ID: 16322259 [TBL] [Abstract][Full Text] [Related]
13. Bcl-2 regulates HIF-1alpha protein stabilization in hypoxic melanoma cells via the molecular chaperone HSP90. Trisciuoglio D; Gabellini C; Desideri M; Ziparo E; Zupi G; Del Bufalo D PLoS One; 2010 Jul; 5(7):e11772. PubMed ID: 20668552 [TBL] [Abstract][Full Text] [Related]
14. Heat shock protein 90 promotes epithelial to mesenchymal transition, invasion, and migration in colorectal cancer. Nagaraju GP; Long TE; Park W; Landry JC; Taliaferro-Smith L; Farris AB; Diaz R; El-Rayes BF Mol Carcinog; 2015 Oct; 54(10):1147-58. PubMed ID: 24861206 [TBL] [Abstract][Full Text] [Related]
15. Antiangiogenic effects of a novel synthetic curcumin analogue in pancreatic cancer. Nagaraju GP; Zhu S; Ko JE; Ashritha N; Kandimalla R; Snyder JP; Shoji M; El-Rayes BF Cancer Lett; 2015 Feb; 357(2):557-65. PubMed ID: 25497868 [TBL] [Abstract][Full Text] [Related]
16. Sestrin2 inhibits hypoxia-inducible factor-1α accumulation via AMPK-mediated prolyl hydroxylase regulation. Seo K; Seo S; Ki SH; Shin SM Free Radic Biol Med; 2016 Dec; 101():511-523. PubMed ID: 27840318 [TBL] [Abstract][Full Text] [Related]
17. Dimethyl fumarate inhibits the expression and function of hypoxia-inducible factor-1α (HIF-1α). Zhao G; Liu Y; Fang J; Chen Y; Li H; Gao K Biochem Biophys Res Commun; 2014 Jun; 448(3):303-7. PubMed ID: 24569076 [TBL] [Abstract][Full Text] [Related]
18. Kamebakaurin inhibits the expression of hypoxia-inducible factor-1α and its target genes to confer antitumor activity. Wang KS; Ma J; Mi C; Li J; Lee JJ; Jin X Oncol Rep; 2016 Apr; 35(4):2045-52. PubMed ID: 26781327 [TBL] [Abstract][Full Text] [Related]
19. Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells. Chen MC; Lee CF; Huang WH; Chou TC Biochem Pharmacol; 2013 May; 85(9):1278-87. PubMed ID: 23416116 [TBL] [Abstract][Full Text] [Related]
20. ERRα augments HIF-1 signalling by directly interacting with HIF-1α in normoxic and hypoxic prostate cancer cells. Zou C; Yu S; Xu Z; Wu D; Ng CF; Yao X; Yew DT; Vanacker JM; Chan FL J Pathol; 2014 May; 233(1):61-73. PubMed ID: 24425001 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]